Sachem Capital Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Sachem Capital Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $57.50M | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $64.75M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $52.28M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $30.42M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $18.60M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $12.68M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $11.71M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $7.00M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $4.13M | Apr 2, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.31M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | ($39.57M) | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $15.90M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $20.91M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $13.32M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $8.99M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $6.20M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $7.77M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $4.86M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $3.05M | Apr 2, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($17.78M) | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $15.04M | Mar 31, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.66M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $12.89M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $21.85M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $13.15M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $27.81M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $9.63M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $8.12M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $6.22M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $4.84M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $3.70M | Apr 2, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $1.58M | Mar 31, 2023 |
| FY2022 | Dec 31, 2021 | $822.3K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $148.9K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $241.9K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $710.8K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $92.8K | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $0 | Apr 2, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $460.05M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $491.98M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $620.89M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $565.66M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $417.96M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $226.67M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $141.21M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $86.01M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $67.49M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $38.37M | Apr 2, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $285.11M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $310.33M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $390.82M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $347.95M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $237.88M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $145.75M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $58.65M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $33.21M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $12.93M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $9.88M | Apr 2, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $174.94M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $181.65M | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | $230.08M | Mar 13, 2026 |
| FY2024 | Dec 31, 2022 | $217.71M | Mar 31, 2025 |
| FY2023 | Dec 31, 2021 | $180.08M | Apr 1, 2024 |
| FY2021 | Dec 31, 2020 | $80.92M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $82.56M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $52.80M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $54.57M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | $28.49M | Apr 2, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $391.0K | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $391.0K | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $391.0K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $391.0K | Apr 1, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | ($20.12M) | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | ($8.00M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($4.99M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($2.89M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($1.27M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($405.5K) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $1.24M | Mar 29, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.92M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $18.07M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $12.60M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $23.71M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $41.94M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $19.41M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $18.84M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $99.3K | Mar 30, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $230.24M | Mar 31, 2025 |
| FY2023 | Dec 31, 2023 | $288.40M | Apr 1, 2024 |
| FY2022 | Dec 31, 2022 | $288.40M | Mar 31, 2023 |
| FY2019 | Dec 31, 2019 | $784.1K | Mar 30, 2020 |
| FY2018 | Dec 31, 2018 | $291.0K | Mar 29, 2019 |
| FY2017 | Dec 31, 2017 | $301.1K | Apr 2, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 2, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 2, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 47.68M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | 46.97M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | 46.77M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 41.09M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 32.73M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 22.12M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 22.12M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 15.44M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 15.42M | Mar 29, 2019 |
| FY2017 | Dec 31, 2016 | 15.42M | Apr 2, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.50M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $16.51M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $21.93M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $18.81M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $12.27M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $7.96M | Mar 31, 2022 |